Position in MGNX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$48,069
+$7,884 QoQ
Shares Held
16,633
-30.5% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in MGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STIFEL FINANCIAL CORP holds $433,142,280 across 103 Biotechnology names. MGNX ranks #99 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BHVN |
Biohaven Ltd.
|
9,940,885 | $84,099,887 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
161,052 | $71,916,158 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
48,907 | $37,787,502 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
139,514 | $26,375,120 | |
| 5 | OMER |
Omeros Corp
|
1,831,585 | $19,341,536 | |
| 6 | MANE |
Veradermics, Inc
|
294,117 | $18,573,488 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
49,954 | $16,528,277 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
196,703 | $14,770,427 |
All Filings in MGNX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $48,069 | 16,633 | Shares | Defined | 2026-05-12 | |
| 2025-09-30 | $40,185 | 23,920 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $31,721 | 26,217 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $34,763 | 27,373 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $84,048 | 25,861 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $131,231 | 39,888 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $141,567 | 33,310 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $531,318 | 36,095 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $416,343 | 43,279 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $201,246 | 43,186 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $302,371 | 56,518 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $431,447 | 60,174 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $406,256 | 60,545 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $244,144 | 70,562 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $201,836 | 68,419 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $384,089 | 43,597 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $559,262 | 34,845 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $813,330 | 38,841 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,183,585 | 44,065 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $906,259 | 28,454 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $480,540 | 21,021 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $488,509 | 19,393 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $578,055 | 20,704 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $267,429 | 45,950 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||